Investing.com - Vaxart (NASDAQ: VXRT) reported first quarter EPS of $-0.1100, $0.04 better than the analyst estimate of $-0.1467. Revenue for the quarter came in at $3.24M versus the consensus estimate of $833.33K.
Vaxart's stock price closed at $1.1000. It is up 73.7800% in the last 3 months and up 44.7200% in the last 12 months.
Vaxart saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Vaxart's stock price’s past reactions to earnings here.
According to InvestingPro, Vaxart's Financial Health score is "fair performance".
Check out Vaxart's recent earnings performance, and Vaxart's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar